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hticense.Abstract Background: Recurrent intermittent hypoxia and subsequent increased sympathetic ner-
vous system activity have been adopted as possible mechanisms underlying cardiac rhythm distur-
bances in obstructive sleep apnea syndrome (OSAS).
Methods: We analyzed nocturnal heart rate variability (HRV) in 80 patients (74 males, 6
females, mean age 47.01 ± 10 yrs) with polysomnographically veriﬁed OSAS to assess the changes
in nocturnal HRV indices, and to investigate the correlation between these changes to the severity
of OSAS. The 80 patients were subdivided into 2 subgroups based upon the severity of OSAS; the
ﬁrst subgroup consisted of 27 patients with mild-to-moderate OSAS, while the second subgroup
consisted of 53 patients with severe OSAS. For control group, 25 healthy individuals were included
in the study.
Results: In time-domain analysis, the mean of the standard deviation of all RR intervals for all
5-min segments (SDNN index) was signiﬁcantly different between patients with OSAS and control
as well as among different stages of severity of OSAS (p= 0.02, and p= 0.046, respectively). The
standard deviation of all RR intervals (SDNN) was signiﬁcantly different between patients with
OSAS and control (p= 0.039). HRV triangular index was signiﬁcantly different among different
stages of severity of OSAS (p= 0.023). Frequency-domain variables namely total power, very
low frequency (VLF) power, and low frequency (LF) power were signiﬁcantly increased in patients
with OSAS in comparison to control (p= 0.01, p= 0.024, and p= 0.018, respectively), as well as
among OSAS subgroups (p= 0.01, p= 0.02, and p= 0.04, respectively). Stepwise multiple logistic
regression analysis revealed that AHI correlated positively with SDNN (r= 0.247, p= 0.036),
SDNN index (r= 0.306, p= 0.009), total power (r= 0.323, p= 0.006), VLF power (r= 0.248,
p= 0.037), LF power (r= 0.384, p= 0.001), and LF/HF ratio (r= 0.342, p= 0.004), but corre-
lated negatively with RR interval (r= 0.247, p= 0.036).e Egyptian Society of Chest
g by Elsevier
of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
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188 I. GalalConclusion: OSAS predisposes to clinically signiﬁcant nocturnal impairment of the cardiac auto-
nomic function as evidenced by nocturnal HRV analysis and this impairment was correlated to the
severity of OSAS. Accordingly, HRV can serve as a simple, powerful screening tool for cases with
suspected OSAS.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
Obstructive sleep apnea syndrome (OSAS) is a common disor-
der affecting at least 2–4% of the adult population. The signs,
symptoms and consequences of OSAS are a direct result of the
derangements that occur due to repetitive collapse of the upper
airway: sleep fragmentation, hypoxemia, hypercapnia, marked
swings in intrathoracic pressure, and increased sympathetic
activity [1].
Several previous studies have demonstrated relationships
between sleep disordered breathing (SDB) and cardiac
arrhythmias [2–7]. In OSAS, the recurrence of apneas all
through the night elicits a typical and cyclic heart rate pattern
consisting of cyclical brady/tachycardia [8]. Proposed mecha-
nisms to explain these changes include the potentially
pro-arrhythmic contributions of apnea-induced hypoxia and
increased sympathetic nervous system activity [9–12].
The variation in the time period separating consecutive
heartbeats has come to be conventionally described as heart
rate variability (HRV). Over the last 25 years, HRV analysis
has established itself as a non-invasive research and clinical
tool for indirectly investigating both cardiac and autonomic
system function in both health and disease [13].
Polysomnography (PSG) represents the ‘‘gold standard’’
for obtaining a reliable diagnosis of OSAS. Owing to the in-
creased prevalence of OSAS as well as the elevated cost for
performing PSG, there is a strong need for the development
of reliable low–cost techniques for the diagnosis of this
condition.
The main goal of this study was to characterize the changes
in nocturnal HRV measurements among patients with poly-
somnographically veriﬁed OSAS and to investigate the correla-
tion between these changes and the severity of OSAS.
Materials & methods
The population under study consisted of randomly selected 80
patients with PSG conﬁrmed OSAS. The 80 patients were
subdivided into 2 subgroups; the ﬁrst subgroup consisted of 27
patients with mild-to-moderate OSAS, while the second sub-
group consisted of 53 patients with severe OSAS. Exclusion cri-
teria were hypertension, recent myocardial infarction, heart
failure, history of alcohol intake, and history of operations of
continuous positive airway pressure (CPAP) treatment for
OSAS. For control group, 25 healthy individuals were included
in the study. This study was approved by the local ethical com-
mittee of the Faculty of Medicine at Ain Shams University.
Polysomnography
Nocturnal full night PSG was performed for OSAS patients
and control using a 24 channel computerized system (N4000Embla, Somnologica, Iceland) including the monitoring of
electroencephalogram (EEG), submental and anterior tibial
electromyogram (EMG), oxygen saturation, electrocardio-
gram (ECG), inductance plethysmography of chest wall and
abdomen, nasal pressure sensor, and oronasal thermister.
The parameters, settings, ﬁlters, technical speciﬁcations, sleep
stage scoring and event scoring were done in accordance with
the American Academy of Sleep Medicine (AASM) Manual
for the Scoring of Sleep and Associated Events [14].
Obstructive apnea was deﬁned as the cessation of airﬂow
for at least 10 seconds with persistent respiratory effort. Hypo-
pnea was deﬁned as a 30% or greater decrease in ﬂow lasting
at least 10 s and associated with a 4% or greater oxyhemoglo-
bin desaturation. An alternative deﬁnition for hypopnea was a
50% or greater reduction in ﬂow lasting at least 10 s and asso-
ciated with either 3% or greater oxyhemoglobin desaturation
or an arousal. Total obstructive apnea–hypopnea index
(AHI) was calculated as the number of obstructive apneas
and hypopneas per hour of total sleep time (TST). Time in
bed (TIB), TST, duration of rapid eye movement (REM)
stage, duration of non-rapid eye movement (NREM) stage
including both light sleep stages (stage 1 & 2 NREM sleep)
and deep sleep stages (stage 3 & 4 NREM sleep), sleep latency
as well as REM latency were measured. Arousal index (ArI)
was calculated as the number of arousals per hour of TST.
The threshold for diagnosis of OSAS was set at an AHIP 5
and the severity of OSAS was arbitrarily deﬁned by cut-off
levels of AHI; 5–30 episodes per hour of TST for mild-to-
moderate, and more than 30 episodes per hour of TST for
severe.Heart rate variability analysis
Electrocardiographic signals acquired by the PSG were digital-
ized. The analysis was done only for normal beats. HRV was
evaluated by using both time and frequency-domain variables.
Time-domain variables include; the average length between
each QRS complex (average RR interval), the standard devia-
tion of all RR intervals (SDNN), the mean of the standard devi-
ation of all RR intervals for all 5-min segments (SDNN index),
the square root of the mean of the sum of the squares of differ-
ences between adjacent RR intervals (RMSSD), the number of
pairs of adjacent RR intervals differing by more than 50 ms in
the entire analysis interval (NN50 count), the NN50 count di-
vided by the total number of all RR intervals (NN50 of total
HR%), standard deviation of average NN interval (SDANN),
and the total number of RR intervals divided by maximum
height of the histogram excluding boundaries (HRV triangular
index). In frequency-domain analysis, the power was calculated
for very low frequency (VLF, 0.0033–0.04 Hz), low frequency
(LF, 0.04–0.15 Hz), and high frequency bands (HF, 0.15–
0.4 Hz) as well as the LF/HF ratio.
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Statistical data analysis was carried out using the Statistical
Package for Social Sciences software (SPSS for Windows, ver-
sion 17.0; SPSS Inc, Chicago, IL). Descriptive statistics were
presented as mean ± standard deviation (SD). Analyses of
subgroups according to the severity of OSAS were performed
with independent t-test. Comparisons between control and dif-
ferent stages of OSAS severity were done using analysis of var-
iance (ANOVA) test or the Kruskal–Wallis test. Correlation
analysis was done using Spearman’s correlation analysis test.
Statistical signiﬁcance was set at p< 0.05.Results
Of the 80 OSAS study patients, 74 (92.5%) patients were males
whereas 6 patients (7.5%) were females. The mean (SD) of age
was 47.01 (10) years, with a range of 29 to 73 years. The 25
subjects in the control group were 17 (68%) males whereas
the remaining 8 (32%) subjects were females. The differences
of the mean values of age (47.01 ± 10 vs. 38.45 ± 16.95,
respectively), TIB (463.38 ± 39.79 vs. 464.8 ± 38.21, respec-
tively), and TST (369.82 ± 88.87 vs. 349.32 ± 89.02) were sta-
tistically non-signiﬁcant between patients with OSAS and
control. The duration of light sleep (stages 1 & 2 NREM sleep)
signiﬁcantly increased in OSAS in comparison to control
(p= 0.000), whereas the duration of both REM stage and
deep sleep (stages 3 & 4 NREM sleep) signiﬁcantly decreased
in OSAS in comparison to control (p= 0.001 and
p= 0.003, respectively). REM stage latency as well as ArI sig-
niﬁcantly increased in OSAS in comparison to control
(p= 0.000 and p= 0.000, respectively). Both time and fre-
quency-domain variables of HRV analysis among the patientsTable 1 Demography, Sleep proﬁles, Respiratory events & HRV v
Variable OSAS (n= 80)
Mean ± SD
Age (yrs) 47.01 ± 10
BMI (kg/m2) 36.85 ± 8.44
TIB (min) 463.38 ± 39.79
TST (min) 369.82 ± 88.87
S1 & S2 (%) 69.59 ± 15.87
S3 & S4 (%) 14.87 ± 16.48
REM (%) 15.93 ± 9.05
AHI (event/h of TST) 51.72 ± 32.88
ArI (number/h of TST) 47.68 ± 24.04
SL (min) 15.89 ± 15.61
RL (min) 154.3 ± 87.94
RR Interval (ms) 818.93 ± 107.12
SDNN (ms) 101.56 ± 43.45
SDNN index (ms) 78.46 ± 44.01
RMSSD (ms) 66.08 ± 63.17
NN50 count 4627.13 ± 4659.27
NN50 of total HR (%) 15.18 ± 16.19
SDANN (ms) 90.14 ± 123.5
HRV TI 18.35 ± 7.18
Average Total Power (ms2) 14576.89 ± 8131.54
Average VLF power (ms2) 8874.31 ± 6078.2
Average LF power (ms2) 4104.54 ± 3259.66
Average HF power (ms2) 1379.28 ± 894.62
LF/HF ratio 4.2 ± 4.8with OSAS and control are listed in Table 1 with comparison
between the two groups. In time-domain analysis, only SDNN
and SDNN index were signiﬁcantly increased in OSAS in com-
parison to control (p= 0.039, and p= 0.02, respectively) {Ta-
ble 1}. Frequency-domain variables namely total power, VLF
power, and LF power were signiﬁcantly increased in OSAS in
comparison to control (p= 0.01, p= 0.024, and p= 0.018,
respectively) Table 1.
AHI, apnea–hypopnea index; ArI, arousal index; BMI,
body mass index; HF, high frequency; HR, heart rate; HRV
TI, heart rate variability triangular index; LF, low frequency;
NN50, the number of interval differences of successive NN
intervals greater than 50 ms; OSAS, obstructive sleep apnea
syndrome; REM, rapid eye movement sleep stage; RL, REM
latency; RMSSD, square root of the mean squared differences
of successive NN intervals; S1, stage 1 sleep; S2, stage 2 sleep;
S3, stage 3 sleep; S4, stage 4 sleep; SDANN, standard devia-
tion of average NN interval; SDNN, standard deviation of
NN interval; SL, sleep latency; VLF, very low frequency.
Regarding the severity of OSAS; 27 patients (33.75%) had
mild-to-moderate OSAS, while the remaining 53 patients
(66.25%) had severe OSAS. The mean AHI for mild-to-mod-
erate OSAS subgroup was 15.46 ± 8.2, and 70.18 ± 24.05
for severe OSAS subgroup. The differences of the mean values
of age (47.46 ± 9.57 vs. 46.79 ± 10.29, respectively), body
mass index {BMI} (35.26 ± 7.49 vs. 37.63 ± 8.83, respec-
tively), TIB (471.28 ± 55.88 vs. 459.58 ± 29.07, respectively),
and TST (376.14 ± 96.57 vs. 366.85 ± 85.86) were statistically
non-signiﬁcant between mild-to-moderate, and severe OSAS
subgroups. The duration of light sleep (stages 1 & 2 NREM
sleep) increased with the increase in the severity of OSAS
(p= 0.001), whereas the duration of REM stage decreased
with the increase in the severity of OSAS (p= 0.002). REM
stage latency was signiﬁcantly different among different stagesariables in patients with OSAS & Control.
Control (n= 25) P
Mean ± SD
38.45 ± 16.95 0.264
31.87 ± 6.17 0.006
464.8 ± 38.21 0.47
349.32 ± 89.02 0.477
58.35 ± 11.32 0.000
20.01 ± 14.08 0.003
21.58 ± 11.64 0.001
2.07 ± 1.41 0.000
22.79 ± 17.36 0.000
30.84 ± 53.38 0.681
117.11 ± 74.52 0.000
837.08 ± 90.5 0.293
84.44 ± 30.65 0.039
58.28 ± 20.73 0.02
46.4 ± 36.16 0.165
5225.72 ± 6614.14 0.43
16.18 ± 17.59 0.562
79.16 ± 79.31 0.382
17.44 ± 6.54 0.099
11124.5 ± 2704.69 0.01
6460.44 ± 2370.23 0.024
3055.92 ± 1053.41 0.018
1437.16 ± 743.13 0.755
2.87 0.104
Table 2 Demography, Sleep proﬁles, Respiratory events & HRV variables in subgroups of patients with OSAS.
Variable Mild-to-Moderate OSAS (n= 27) Severe OSAS (n= 53) P
Mean ± SD Mean ± SD
Age (yrs) 47.46 ± 9.57 46.79 ± 10.29 0.782
BMI (kg/m2) 35.26 ± 7.49 37.63 ± 8.83 0.244
TIB (min) 471.28 ± 55.88 459.58 ± 29.07 0.229
TST (min) 376.14 ± 96.57 366.85 ± 85.86 0.676
S1 & S2 (%) 60.94 ± 10.62 73.66 ± 16.37 0.001
S3 & S4 (%) 18.39 ± 13.72 13.21 ± 17.51 0.216
REM (%) 20.67 ± 8.48 13.66 ± 8.49 0.002
AHI (event/h of TST) 15.46 ± 8.2 70.18 ± 24.05 0.000
ArI (number/h of TST) 28.4 ± 18.8 56.37 ± 20.98 0.000
SL (min) 16.5 ± 15.16 15.6 ± 15.97 0.818
RL (min) 101.73 ± 62.01 181.83 ± 87.49 0.000
RR Interval (ms) 841.91 ± 91.27 808.14 ± 113.06 0.215
SDNN (ms) 88.65 ± 34.58 107.61 ± 46.12 0.084
SDNN index (ms) 63.44 ± 32.46 85.51 ± 47.15 0.046
RMSSD (ms) 59.57 ± 54.8 69.14 ± 67.04 0.552
NN50 count 3887.87 ± 4502.38 4974.12 ± 4736.57 0.36
NN50 of total HR (%) 13.49 ± 15.76 15.97 ± 16.48 0.549
SDANN (ms) 131.04 ± 209.94 70.94 ± 34.36 0.054
HRV TI 15.57 ± 4.88 19.65 ± 7.75 0.023
Average Total Power (ms2) 10895.46 ± 3792.61 16229.78 ± 9007.45 0.01
Average VLF power (ms2) 6417.91 ± 3232.71 9977.18 ± 6730.38 0.02
Average LF power (ms2) 2924.18 ± 1026.62 4634.49 ± 3756.19 0.04
Average HF power (ms2) 1387.27 ± 922.08 1375.69 ± 891.71 0.96
LF/HF ratio 2.82 ± 1.86 4.82 ± 5.55 0.105
Table 3 Correlation between AHI & HRV indices.
Variable AHI (n= 80)
r P
RR inerval (ms) 0.247 0.036
SDNN (ms) 0.247 0.036
SDNN index (ms) 0.306 0.009
RMSSD (ms) 0.194 0.102
NN50 count 0.185 0.119
NN50 of total HR (%) 0.161 0.177
SDANN (ms) 0.194 0.102
HRV TI 0.172 0.149
Average Total Power (ms2) 0.323 0.006
Average VLF power (ms2) 0.248 0.037
Average LF power (ms2) 0.384 0.001
Average HF power (ms2) 0.087 0.469
LF/HF ratio 0.342 0.004
190 I. Galalof severity of OSAS (p= 0.000). ArI signiﬁcantly increased
with the increase in the severity of OSAS (p= 0.000). Both
time-domain and frequency-domain variables of HRV analysis
among the different subgroups of OSAS severity are listed in
Table 2 with comparison between the different subgroups. In
time-domain analysis, SDNN index, and HRV triangular in-
dex variables were signiﬁcantly different among different
stages of severity of OSAS (p= 0.046, and p= 0.023, respec-
tively) being greater in severe OSAS subgroup for both SDNN
index and HRV triangular index variables (Table 2). Fre-
quency-domain variables namely average total power, average
VLF power, and average LF power were signiﬁcantly different
among the subgroups (p= 0.01, p= 0.02, and p= 0.04,
respectively) {Table 2}.
AHI, apnea–hypopnea index; ArI, arousal index; BMI,
body mass index; HF, high frequency; HR, heart rate; HRV
TI, heart rate variability triangular index; LF, low frequency;
NN50, the number of interval differences of successive NN
intervals greater than 50 ms; OSAS, obstructive sleep apnea
syndrome; REM, rapid eye movement sleep stage; RL, REM
latency; RMSSD, square root of the mean squared differences
of successive NN intervals; S1, stage 1 sleep; S2, stage 2 sleep;
S3, stage 3 sleep; S4, stage 4 sleep; SDANN, standard devia-
tion of average NN interval; SDNN, standard deviation of
NN interval; SL, sleep latency; VLF, very low frequency.
AHI was correlated with different HRV indices; AHI corre-
lated positively with SDNN (r= 0.247,p= 0.036), SDNN in-
dex (r= 0.306,p= 0.009), average total power (r= 0.323,
p= 0.006), average VLF power (r= 0.248,p= 0.037), aver-
age LF power (r= 0.384,p= 0.001), and LF/HF ratio
(r= 0.342,p= 0.004), but correlated negatively with RR
interval (r= 0.247,p= 0.036) {Table 3 & Figs. 1–7}.AHI, apnea–hypopnea index; HF, high frequency; HR,
heart rate; HRV TI, heart rate variability triangular index;
LF, low frequency; NN50, the number of interval differences
of successive NN intervals greater than 50 ms; RMSSD,
square root of the mean squared differences of successive
NN intervals; SDANN, standard deviation of average NN
interval; SDNN, standard deviation of NN interval; VLF, very
low frequency.
Discussion
It is well known that in patients with OSAS, the heart rate
(HR) usually slows during the apnea and then increases
markedly as the subject takes a breath [8]. These respiratory
Figure 1 Correlation between AHI and RR interval in OSAS.
Figure 2 Correlation between AHI and SDNN variable in OSAS.
Nocturnal heart rate variability analysis as a screening tool for obstructive sleep apnea syndrome 191
Figure 3 Correlation between AHI and SDNN index in OSAS.
Figure 4 Correlation between AHI and total power in OSAS.
192 I. Galalevent-related hypoxemia and arousal results in autonomic ner-
vous system (ANS) dysregulation in the form of enhanced
sympathetic nervous system activity that is thought to be
implicated in the occurrence of HRV [15].
The main goal of this study was to characterize the changes
in nocturnal HRV measurements among patients with OSAS
and to investigate the correlation between these changes and
the severity of OSAS.
Previous studies have documented that the repetitive upper
airway obstructions in OSAS during sleep causes an initial
stimulation of the parasympathetic ANS, this is followed by
an abrupt activation of the sympathetic ANS as a result of
occurrence of hypoxemia and hypercapnia (acting throughthe chemoreﬂexes). Thus, at night, the alternate strong succes-
sive parasympathetic and sympathetic drives dramatically en-
hance RR variability [16,17].
In the past, time-domain HRV was used frequently. In
1981, Akselrod et al. [18] introduced power spectral analysis
of heart rate ﬂuctuations to quantitatively evaluate beat-to-
beat cardiovascular control. These frequency domain analyses
contributed to the understanding of autonomic background of
RR interval ﬂuctuations in the heart rate record [19,20]. Spec-
tral analysis gives selective information on parasympathetic
and sympathetic function [12].
The principal ﬁndings of this study indicated that most of
the frequency-domain variables (or spectral analysis) of
Figure 5 Correlation between AHI and VLF power in OSAS.
Figure 6 Correlation between AHI and LF power in OSAS.
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average LF power were the more sensitive measures differenti-
ating patients with OSAS from control being higher in the
OSAS group of patients in comparison to control. Moreover,
the same variables were also sensitive in discrimination OSAS
patients with mild-to-moderate stage of severity from those
with severe OSAS being higher in the severe subgroup in com-
parison to the mild-to-moderate subgroup. On the other hand,
time-domain variables failed to discriminate signiﬁcantly be-
tween the two subgroups. Only SDNN and SDNN index were
signiﬁcantly different between patients with OSAS and con-
trol. Similarly, only SDNN index and HRV triangular indextime-domain variables were able to discriminate signiﬁcantly
between patients with mild-to-moderate OSAS from those
with severe OSAS. One of the possible explanations for the
reason why most time-domain variables were not better than
frequency domain variables in this study is that frequency do-
main techniques may be better than time-domain analysis in
the precise evaluation of changes of sympatho-vagal balance
[21]. The LF component has been regarded as a parameter
reﬂecting sympathetic activity. Changes in the LF band spec-
tral power reﬂect a combination of sympathetic and parasym-
pathetic ANS outﬂow variations, while changes in the HF
band spectral power reﬂect vagal modulation of cardiac
Figure 7 Correlation between AHI and LF/HF variable in OSAS.
194 I. Galalactivity. The LF/HF power ratio is used as an index for assess-
ing sympatho-vagal balance. Thus, the changes in HRV in this
study might suggest that in patients with OSAS, the impair-
ment of the ANS is due to sympathetic stimulation and lack
or withdrawal of parasympathetic activity. This is not surpris-
ing on basis of the assumption that parasympathetic control
for heart rate has a very short latency enabling a beat-to-beat
basis change, but synaptic nor-epinephrine mediating sympa-
thetic inﬂuence is metabolized relatively slowly [21]. The
HRV triangular index tends to correlate with total power in
frequency domain analysis. It also reﬂects the overall amount
of variability and has known to be affected by both sympa-
thetic and parasympathetic activity but more inﬂuenced by
lower bands than higher bands [21]. Although SDNN and
SDNN index seemed to carry a degree of signiﬁcance in OSAS
in this study besides being long considered to reﬂect estimate of
overall HRV[12] yet, it is noteworthy that in many previous
studies it is indicated that time-domain features are calculated
over 24 hours (long term) recordings, while frequency-domain
features are calculated over 2–5 min (short term) recordings
[22,23] .Thus, SDNN being a time-domain variable, is better
to be calculated over a 24-hour period especially that SDNN
reﬂects all the cyclic components responsible for variability
in the period of recording and as the period of monitoring de-
creases, SDNN estimates shorter and shorter cycle lengths and
the total variance of HRV subsequently decreases [24] making
the changes in variables less valuable. Accordingly, the results
of frequency-domain variables in this study should be consid-
ered more seriously than those of time-domain variables be-
cause the duration of recording was only nocturnal.
In this study, the correlation between the severity of OSAS,
represented by AHI, was tested against the different HRV indi-
ces; AHI correlated positively with all frequency-domain vari-
ables except for average HF power, whereas SDNN and
SDNN index of time-domain variables correlated positivelywith AHI but RR interval correlated negatively. The strongest
positive correlation was found in average LF power. Thus,
HRV, especially frequency-domain analysis, in OSAS was not
just helpful in the identiﬁcation of patients with OSAS but
can also be regarded as a guide for the severity of the disease.
Park and colleagues [25] in a recent study investigated the
correlation between the severity of OSAS and HRV indices
among 59 patients with moderate and severe OSAS. Their re-
sults were closely identical to the results in this study; most of
the frequency-domain variables especially total power, VLF
power, LF power as well as HRV triangular index time-domain
variable, were signiﬁcantly increased in severe OSAS compared
with mild-to-moderate OSAS. Moreover, AHI correlated posi-
tively with total power, VLF power, LF power, and LF/HF ra-
tio, but correlated negatively with RR interval. Yet, this study
lacked a healthy control group for comparison. In another
study, similar results were obtained by Aydin and colleagues
[26] who investigated cardiac autonomic activity in 36 patients
with OSAS as well as in 34 control, they reported that total
power, VLF, LF, and LF/HF ratio were higher in OSAS pa-
tients than those of controls, and that LF and LF/HF ratio were
increased in severe OSAS group compared with mild OSAS
group. Moreover, Guilleminault et al. [8] and Le Heuzey et al.
[27] in previous studies suggested using HRV as a tool for pre-
liminary identiﬁcation of OSAS independently of the assistance
of a sleep laboratory. However, some other studies showed con-
tradicting results to those in this study; Yang and colleagues [28]
studied the inﬂuence of obstructive sleep apnea on heart rate
turbulence in 65 patients with OSAS and reported no difference
of either time or frequency-domain variables between
mild-to-moderate andmoderate-to-severe OSAS patients. Gula
and colleagues [29] reported that the LF/HF ratio was higher
among patients with moderate OSAS compared to those with
severe OSAS. These contradicting ﬁndings are not surprising
because the criteria of the population under study in these
Nocturnal heart rate variability analysis as a screening tool for obstructive sleep apnea syndrome 195studies are different, the duration of recording for HRV are var-
iable with different methods for data analysis and variable res-
olution of the devices used.
It is worth mentioning that one of the points of strength in
this study was excluding OSAS patients having clinical disor-
ders causing blunted autonomic activity and subsequent affec-
tion of HRV. Moreover, the inclusion of normal control
healthy group with negative sleep studies in this study acts as
a reference that helps to obtain statistically signiﬁcant results
and represents an additional point of strength in this study.
Yet, the need for assessment of diurnal HRV as well as testing
the impact of CPAP therapy on HRV in patients with OSAS
needs to be further investigated. Nevertheless, the unmatching
of BMI between OSAS patients and control might represent a
limitation in this study.
Conclusion
This study indicates that OSAS predisposes to clinically signif-
icant nocturnal impairment of the cardiac autonomic function
as evidenced by nocturnal HRV analysis mainly through spec-
tral analysis and to lesser extent through time-domain analysis
and this impairment was correlated to the severity of the dis-
ease. Accordingly, HRV represents one of the most simple,
promising tools for the assessment of ANS in patients with
OSAS and can serve as a simple, powerful screening tool for
cases with suspected OSAS.
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